WEBULL
News
ANIK
10.25
-0.77%
-0.08
Weekly Report: what happened at ANIK last week (0202-0206)?
Weekly Report · 3d ago
Positive week for Anika Therapeutics, Inc. (NASDAQ:ANIK) institutional investors who lost 41% over the past year
Simply Wall St · 02/05 10:17
Medacta Group reports 18.5% revenue growth in 2025
Reuters · 02/03 06:01
Weekly Report: what happened at ANIK last week (0126-0130)?
Weekly Report · 02/02 09:47
Weekly Report: what happened at ANIK last week (0119-0123)?
Weekly Report · 01/26 09:47
ANIK INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Anika Therapeutics, Inc.
Barchart · 01/23 19:00
Weekly Report: what happened at ANIK last week (0112-0116)?
Weekly Report · 01/19 09:51
Weekly Report: what happened at ANIK last week (0105-0109)?
Weekly Report · 01/12 09:50
Anika Therapeutics Price Target Maintained With a $16.00/Share by Barrington Research
Dow Jones · 01/09 13:10
Anika Therapeutics Is Maintained at Outperform by Barrington Research
Dow Jones · 01/09 13:10
Barrington Research Maintains Outperform on Anika Therapeutics, Maintains $16 Price Target
Benzinga · 01/09 13:00
Analysts Offer Insights on Healthcare Companies: Tvardi Therapeutics (TVRD) and Anika Therapeutics (ANIK)
TipRanks · 01/09 12:50
Anika Therapeutics Announces CEO Transition and Governance Changes
TipRanks · 01/08 21:37
Anika Therapeutics appoints Stephen Griffin as CEO
Seeking Alpha · 01/08 12:50
Anika Therapeutics Appoints CFO as new CEO
Dow Jones · 01/08 12:49
Anika Therapeutics appoints Griffin as CEO, Blanchard as Executive Chair
TipRanks · 01/08 12:16
CFO And COO Steve Griffin to Take Over as Anika CEO While Cheryl Blanchard Becomes Executive Chair
Benzinga · 01/08 12:10
*Anika Therapeutics Cheryl Blanchard to Become Executive Chair of the Board of Directors >ANIK
Dow Jones · 01/08 12:05
*Anika Therapeutics CFO, COO Stephen Griffin Appointed Pres and CEO >ANIK
Dow Jones · 01/08 12:04
Anika Therapeutics Names Steve Griffin CEO as Cheryl Blanchard Becomes Executive Chair
Reuters · 01/08 12:00
More
Webull provides a variety of real-time ANIK stock news. You can receive the latest news about Anika Therapeutics Inc through multiple platforms. This information may help you make smarter investment decisions.
About ANIK
Anika Therapeutics, Inc. is engaged in the osteoarthritis pain management and regenerative solutions space focused on early intervention orthopedics. The Company is leveraging its core expertise in hyaluronic acid and implant solutions. It partners with clinicians to provide minimally invasive products that restore active living for people around the world. It is developing, manufacturing and commercializing products on its hyaluronic acid (HA) technology platform. It is focused on spaces within orthopedics, including osteoarthritis pain management and regenerative solutions, and its products are delivered in key sites of care, including ambulatory surgery centers. Its products include OA Pain Management, Regenerative Solutions, and others. The OA Pain Management product family consists of Cingal, Monovisc, Orthovisc, Orthovisc mini and Orthovisc-T. Its Regenerative Solutions include Integrity, Hyalofast, Tactoset and NanoFx.